Home » Topics » Inflammatory, BioWorld Science

Inflammatory, BioWorld Science
RSS

Phase I trial to assess MLN-9708 in relapsed/refractory light chain amyloidosis under way

March 28, 2011

Roskamp Institute obtains IRB approval for study of RCP-006 in humans

March 4, 2011

AM-095 displays antifibrotic activity in vivo

Jan. 13, 2011

AZD-9773 enters phase IIb trial in patients with severe sepsis and/or septic shock

Oct. 26, 2010

Almirall identifies new naphthyridine N-oxide as anti-inflammatory agent

Sep. 21, 2010

Positive outcome to decentralized procedure for European approval of Twinject

Sep. 1, 2010

Novel LPA1 receptor antagonists developed at Amira

July 7, 2010

Omeros selects clinical candidate for MASP-2 antibody program

May 14, 2010

Osiris achieves milestone for remestemcel-L development progress in Japan

April 29, 2010

DMC recommends continued enrollment in eritoran phase III trial for severe sepsis

March 26, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...